{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "16",
                "@timestamp": "2023-01-16T19:45:35.000035-05:00",
                "@year": "2023",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2018",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Medical Research Council",
                "xocs:funding-agency-acronym": "MRC",
                "xocs:funding-agency": "Medical Research Council",
                "xocs:funding-id": [
                    {"$": "MC-UU-12023/26"},
                    {"$": "MC-UU-12023/29"}
                ],
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100000265",
                "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
            },
            "xocs:funding-addon-generated-timestamp": "2022-02-05T22:55:28.219Z",
            "xocs:funding-text": "D.F., R.T., A.T., and D.M.G. are supported by core support to the Medical Research Council [MC-UU-12023/26; MC-UU-12023/29].",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United Kingdom",
                            "@afid": "60022148",
                            "@country": "gbr",
                            "city": "London",
                            "organization": [
                                {"$": "MRC Clinical Trials Unit at UCL"},
                                {"$": "University College London"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60022148"},
                                {"@afid": "60003108"}
                            ],
                            "@affiliation-instance-id": "2016633691-c245db6ef9a02a0a7f4251086c44bee4",
                            "ce:source-text": "MRC Clinical Trials Unit at UCL, University College London, London, United Kingdom;"
                        },
                        "author": [
                            {
                                "ce:given-name": "Deborah",
                                "preferred-name": {
                                    "ce:given-name": "Deborah",
                                    "ce:initials": "D.",
                                    "ce:surname": "Ford",
                                    "ce:indexed-name": "Ford D."
                                },
                                "@author-instance-id": "2016633691-ad1c5c3d02d140ec00202db2d9eaf5b2",
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Ford",
                                "@auid": "7401568316",
                                "ce:indexed-name": "Ford D."
                            },
                            {
                                "ce:given-name": "Rebecca",
                                "preferred-name": {
                                    "ce:given-name": "Rebecca",
                                    "ce:initials": "R.",
                                    "ce:surname": "Turner",
                                    "ce:indexed-name": "Turner R."
                                },
                                "@author-instance-id": "2016633691-849a8ff05ded7e3d020b4e9068a537d3",
                                "@seq": "2",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Turner",
                                "@auid": "7404556631",
                                "ce:indexed-name": "Turner R."
                            },
                            {
                                "ce:given-name": "Anna",
                                "preferred-name": {
                                    "ce:given-name": "Anna",
                                    "ce:initials": "A.",
                                    "ce:surname": "Turkova",
                                    "ce:indexed-name": "Turkova A."
                                },
                                "@author-instance-id": "2016633691-f1f2bb8b3f520b5caaebd7bb24da28d5",
                                "@seq": "3",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MRCPCH",
                                "ce:surname": "Turkova",
                                "@auid": "26031175500",
                                "ce:indexed-name": "Turkova A."
                            },
                            {
                                "ce:given-name": "Diana M.",
                                "preferred-name": {
                                    "ce:given-name": "Diana M.",
                                    "ce:initials": "D.M.",
                                    "ce:surname": "Gibb",
                                    "ce:indexed-name": "Gibb D.M."
                                },
                                "@author-instance-id": "2016633691-e509cad34c99cd9cbdc27165d4a2db9a",
                                "@seq": "13",
                                "ce:initials": "D.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Gibb",
                                "@auid": "57220477488",
                                "ce:indexed-name": "Gibb D.M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60027142",
                            "@country": "che",
                            "city": "Geneva",
                            "organization": [
                                {"$": "HIV and Hepatitis Department"},
                                {"$": "World Health Organization"}
                            ],
                            "affiliation-id": {
                                "@afid": "60027142",
                                "@dptid": "122433705"
                            },
                            "@affiliation-instance-id": "2016633691-5e764f6132f0b403ea5bfb14f3beba0b",
                            "ce:source-text": "HIV and Hepatitis Department, World Health Organization, Geneva, Switzerland;",
                            "@dptid": "122433705"
                        },
                        "author": [{
                            "ce:given-name": "Martina",
                            "preferred-name": {
                                "ce:given-name": "Martina",
                                "ce:initials": "M.",
                                "ce:surname": "Penazzato",
                                "ce:indexed-name": "Penazzato M."
                            },
                            "@author-instance-id": "2016633691-70872a97174cc4708834fb1527306203",
                            "@seq": "4",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Penazzato",
                            "@auid": "57192121240",
                            "ce:indexed-name": "Penazzato M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Uganda",
                            "@afid": "60071676",
                            "@country": "uga",
                            "city": "Kampala",
                            "organization": [
                                {"$": "Department of Paediatrics and Child Health"},
                                {"$": "Makerere University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60071676",
                                "@dptid": "104795959"
                            },
                            "@affiliation-instance-id": "2016633691-6ad0b3f0b16f7f2664c8e1041b2a10d4",
                            "ce:source-text": "Department of Paediatrics and Child Health, Makerere University, Kampla, Uganda;",
                            "@dptid": "104795959"
                        },
                        "author": [{
                            "ce:given-name": "Victor",
                            "preferred-name": {
                                "ce:given-name": "Victor",
                                "ce:initials": "V.",
                                "ce:surname": "Musiime",
                                "ce:indexed-name": "Musiime V."
                            },
                            "@author-instance-id": "2016633691-aae8efd5bf572ca63d2e7896a0518d34",
                            "@seq": "5",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Musiime",
                            "@auid": "17135681200",
                            "ce:indexed-name": "Musiime V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Uganda",
                            "@afid": "60071691",
                            "@country": "uga",
                            "city": "Kampala",
                            "organization": [
                                {"$": "Research Department"},
                                {"$": "Joint Clinical Research Centre"}
                            ],
                            "affiliation-id": {
                                "@afid": "60071691",
                                "@dptid": "116512293"
                            },
                            "@affiliation-instance-id": "2016633691-2a98060170121741eed1992340efae52",
                            "ce:source-text": "Research Department, Joint Clinical Research Centre, Kampala, Uganda;",
                            "@dptid": "116512293"
                        },
                        "author": [{
                            "ce:given-name": "Victor",
                            "preferred-name": {
                                "ce:given-name": "Victor",
                                "ce:initials": "V.",
                                "ce:surname": "Musiime",
                                "ce:indexed-name": "Musiime V."
                            },
                            "@author-instance-id": "2016633691-aae8efd5bf572ca63d2e7896a0518d34",
                            "@seq": "5",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Musiime",
                            "@auid": "17135681200",
                            "ce:indexed-name": "Musiime V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Zimbabwe",
                            "@afid": "60033774",
                            "@country": "zwe",
                            "city": "Harare",
                            "organization": [
                                {"$": "2Department of Paediatrics and Child Health"},
                                {"$": "University of Zimbabwe College of Health Sciences"}
                            ],
                            "affiliation-id": {
                                "@afid": "60033774",
                                "@dptid": "104703012"
                            },
                            "@affiliation-instance-id": "2016633691-8db21343f1d0104d3325226e9ee1dd80",
                            "ce:source-text": "2Department of Paediatrics and Child Health, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe;",
                            "@dptid": "104703012"
                        },
                        "author": [{
                            "ce:given-name": "Mutsa",
                            "preferred-name": {
                                "ce:given-name": "Mutsa",
                                "ce:initials": "M.",
                                "ce:surname": "Bwakura-Dangarembizi",
                                "ce:indexed-name": "Bwakura-Dangarembizi M."
                            },
                            "@author-instance-id": "2016633691-48b1848621b3152a8f3ad0781fc1aa3c",
                            "@seq": "6",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MMed",
                            "ce:surname": "Bwakura-Dangarembizi",
                            "@auid": "36670936700",
                            "ce:indexed-name": "Bwakura-Dangarembizi M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Africa",
                            "@afid": "60016218",
                            "@country": "zaf",
                            "city": "Johannesburg",
                            "organization": [
                                {"$": "Perinatal HIV Research Unit (PHRU)"},
                                {"$": "University of the Witwatersrand"}
                            ],
                            "affiliation-id": {"@afid": "60016218"},
                            "@affiliation-instance-id": "2016633691-ad9d02d5b748a08ad1ddd5a6336b1109",
                            "ce:source-text": "Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa;"
                        },
                        "author": [{
                            "ce:given-name": "Avy",
                            "preferred-name": {
                                "ce:given-name": "Avy",
                                "ce:initials": "A.",
                                "ce:surname": "Violari",
                                "ce:indexed-name": "Violari A."
                            },
                            "@author-instance-id": "2016633691-5f98379f926df3049bf167f4ac276936",
                            "@seq": "7",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "FCPaed",
                            "ce:surname": "Violari",
                            "@auid": "8674786700",
                            "ce:indexed-name": "Violari A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Zambia",
                            "@afid": "60072805",
                            "@country": "zmb",
                            "city": "Lusaka",
                            "organization": [
                                {"$": "Department of Paediatrics"},
                                {"$": "University Teaching Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60072805",
                                "@dptid": "100278300"
                            },
                            "@affiliation-instance-id": "2016633691-280f469c19c11c8708ac95116de05759",
                            "ce:source-text": "Department of Paediatrics, University Teaching Hospital, Lusaka, Zambia;",
                            "@dptid": "100278300"
                        },
                        "author": [{
                            "ce:given-name": "Chishala",
                            "preferred-name": {
                                "ce:given-name": "Chishala",
                                "ce:initials": "C.",
                                "ce:surname": "Chabala",
                                "ce:indexed-name": "Chabala C."
                            },
                            "@author-instance-id": "2016633691-a2aa08343d9b413021e67ede401bfc70",
                            "@seq": "8",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MMed",
                            "ce:surname": "Chabala",
                            "@auid": "55444254300",
                            "ce:indexed-name": "Chabala C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Zambia",
                            "@afid": "60072796",
                            "@country": "zmb",
                            "city": "Lusaka",
                            "organization": [
                                {"$": "Department of Paediatrics and Child Health"},
                                {"$": "University of Zambia"}
                            ],
                            "affiliation-id": {
                                "@afid": "60072796",
                                "@dptid": "104816464"
                            },
                            "@affiliation-instance-id": "2016633691-b1e590f462bece1de3464c524afc6d63",
                            "ce:source-text": "Department of Paediatrics and Child Health, University of Zambia, Lusaka, Zambia;",
                            "@dptid": "104816464"
                        },
                        "author": [{
                            "ce:given-name": "Chishala",
                            "preferred-name": {
                                "ce:given-name": "Chishala",
                                "ce:initials": "C.",
                                "ce:surname": "Chabala",
                                "ce:indexed-name": "Chabala C."
                            },
                            "@author-instance-id": "2016633691-a2aa08343d9b413021e67ede401bfc70",
                            "@seq": "8",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MMed",
                            "ce:surname": "Chabala",
                            "@auid": "55444254300",
                            "ce:indexed-name": "Chabala C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Infectious Diseases"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183423"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2016633691-55f73f751c5558049491eadd054231fd",
                            "ce:source-text": "Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;",
                            "@dptid": "103183423"
                        },
                        "author": [{
                            "ce:given-name": "Thanyawee",
                            "preferred-name": {
                                "ce:given-name": "Thanyawee",
                                "ce:initials": "T.",
                                "ce:surname": "Puthanakit",
                                "ce:indexed-name": "Puthanakit T."
                            },
                            "@author-instance-id": "2016633691-8442cf6c96a7d6b867a5c7454b3e1079",
                            "@seq": "9",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Puthanakit",
                            "@auid": "8071686900",
                            "ce:indexed-name": "Puthanakit T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60032250",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Division of Infectious Diseases"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60032250",
                                    "@dptid": "108026253"
                                },
                                {"@afid": "60000881"}
                            ],
                            "@affiliation-instance-id": "2016633691-818a4576412e5a1d6c88e18ec16477e9",
                            "ce:source-text": "Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand;",
                            "@dptid": "108026253"
                        },
                        "author": [{
                            "ce:given-name": "Tavitiya",
                            "preferred-name": {
                                "ce:given-name": "Tavitiya",
                                "ce:initials": "T.",
                                "ce:surname": "Sudjaritruk",
                                "ce:indexed-name": "Sudjaritruk T."
                            },
                            "@author-instance-id": "2016633691-d208f376c487c29b7d03d0f41b0c2f03",
                            "@seq": "10",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Sudjaritruk",
                            "@auid": "36538198800",
                            "ce:indexed-name": "Sudjaritruk T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Research Institute for Health Sciences"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084232"
                            },
                            "@affiliation-instance-id": "2016633691-587e82d86406a5f161705fc6de8150a4",
                            "ce:source-text": "Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand;",
                            "@dptid": "103084232"
                        },
                        "author": [{
                            "ce:given-name": "Tavitiya",
                            "preferred-name": {
                                "ce:given-name": "Tavitiya",
                                "ce:initials": "T.",
                                "ce:surname": "Sudjaritruk",
                                "ce:indexed-name": "Sudjaritruk T."
                            },
                            "@author-instance-id": "2016633691-d208f376c487c29b7d03d0f41b0c2f03",
                            "@seq": "10",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Sudjaritruk",
                            "@auid": "36538198800",
                            "ce:indexed-name": "Sudjaritruk T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "1Department of Medical Technology"},
                                {"$": "PHPT/IRD 174"},
                                {"$": "Faculty of Associated Medical Sciences"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084128"
                            },
                            "@affiliation-instance-id": "2016633691-214aeecaea97b6eb876319cccf580d41",
                            "ce:source-text": "1Department of Medical Technology, PHPT/IRD 174, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand;",
                            "@dptid": "103084128"
                        },
                        "author": [
                            {
                                "ce:given-name": "Tim R.",
                                "preferred-name": {
                                    "ce:given-name": "Tim R.",
                                    "ce:initials": "T.R.",
                                    "ce:surname": "Cressey",
                                    "ce:indexed-name": "Cressey T.R."
                                },
                                "@author-instance-id": "2016633691-55bd276c53a1899847364e0e4c26a7a7",
                                "@seq": "11",
                                "ce:initials": "T.R.",
                                "@date-locked": "2022-03-12T09:54:04.543",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Cressey",
                                "@auid": "55966228800",
                                "ce:indexed-name": "Cressey T.R."
                            },
                            {
                                "ce:given-name": "Marc",
                                "preferred-name": {
                                    "ce:given-name": "Marc",
                                    "ce:initials": "M.",
                                    "ce:surname": "Lallemant",
                                    "ce:indexed-name": "Lallemant M."
                                },
                                "@author-instance-id": "2016633691-88b4a381793e1ca81a3c2b25987d0f61",
                                "@seq": "12",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Lallemant",
                                "@auid": "24387959100",
                                "ce:indexed-name": "Lallemant M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60032499",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Department of Immunology & Infectious Diseases"},
                                {"$": "Harvard T.H Chan School of Public Health"}
                            ],
                            "affiliation-id": {
                                "@afid": "60032499",
                                "@dptid": "113494521"
                            },
                            "state": "MA",
                            "@affiliation-instance-id": "2016633691-e9eb07d3ba8e73901ade7cbc537e7685",
                            "ce:source-text": "Department of Immunology & Infectious Diseases, Harvard T.H Chan School of Public Health, Boston, MA; and",
                            "@dptid": "113494521"
                        },
                        "author": [
                            {
                                "ce:given-name": "Tim R.",
                                "preferred-name": {
                                    "ce:given-name": "Tim R.",
                                    "ce:initials": "T.R.",
                                    "ce:surname": "Cressey",
                                    "ce:indexed-name": "Cressey T.R."
                                },
                                "@author-instance-id": "2016633691-55bd276c53a1899847364e0e4c26a7a7",
                                "@seq": "11",
                                "ce:initials": "T.R.",
                                "@date-locked": "2022-03-12T09:54:04.543",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Cressey",
                                "@auid": "55966228800",
                                "ce:indexed-name": "Cressey T.R."
                            },
                            {
                                "ce:given-name": "Marc",
                                "preferred-name": {
                                    "ce:given-name": "Marc",
                                    "ce:initials": "M.",
                                    "ce:surname": "Lallemant",
                                    "ce:indexed-name": "Lallemant M."
                                },
                                "@author-instance-id": "2016633691-88b4a381793e1ca81a3c2b25987d0f61",
                                "@seq": "12",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Lallemant",
                                "@auid": "24387959100",
                                "ce:indexed-name": "Lallemant M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United Kingdom",
                            "@afid": "60020661",
                            "@country": "gbr",
                            "city": "Liverpool",
                            "organization": [
                                {"$": "Department of Molecular & Clinical Pharmacology"},
                                {"$": "University of Liverpool"}
                            ],
                            "affiliation-id": {
                                "@afid": "60020661",
                                "@dptid": "118640222"
                            },
                            "@affiliation-instance-id": "2016633691-efa95f174b959e7bc45288b9a2272a42",
                            "ce:source-text": "Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.",
                            "@dptid": "118640222"
                        },
                        "author": [{
                            "ce:given-name": "Tim R.",
                            "preferred-name": {
                                "ce:given-name": "Tim R.",
                                "ce:initials": "T.R.",
                                "ce:surname": "Cressey",
                                "ce:indexed-name": "Cressey T.R."
                            },
                            "@author-instance-id": "2016633691-55bd276c53a1899847364e0e4c26a7a7",
                            "@seq": "11",
                            "ce:initials": "T.R.",
                            "@date-locked": "2022-03-12T09:54:04.543",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Cressey",
                            "@auid": "55966228800",
                            "ce:indexed-name": "Cressey T.R."
                        }]
                    }
                ],
                "citation-title": "Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV",
                "abstracts": "Copyright © 2018 The Author(s).For HIV-infected children, formulation development, pharmacokinetic (PK) data, and evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence of efficacy in children may not be needed if acceptable safety and PK parameters are demonstrated in children. However, it is important to address questions where adult trial data cannot be extrapolated to children. In this fast-moving area, interventions need to be tailored to resource-limited settings where most HIV-infected children live and take account of decreasing numbers of younger HIV-infected children after successful prevention of mother-to-child HIV transmission. Innovative randomized controlled trial (RCT) designs enable several questions relevant to children\u2019s treatment and care to be answered within the same study. We reflect on key considerations, and, with examples, discuss the relative merits of different RCT designs for addressing multiple scientific questions including parallel multi-arm RCTs, factorial RCTs, and crossover RCTs. We discuss inclusion of several populations (eg, untreated and pretreated children; children and adults) in \u201cbasket\u201d trials; incorporation of secondary randomizations after enrollment and use of nested substudies (particularly PK and formulation acceptability) within large RCTs. We review the literature on trial designs across other disease areas in pediatrics and rare diseases and discuss their relevance for addressing questions relevant to HIV-infected children; we provide an example of a Bayesian trial design in prevention of mother-to-child HIV transmission and consider this approach for future pediatric trials. Finally, we discuss the relevance of these approaches to other areas, in particular, childhood tuberculosis and hepatitis.",
                "correspondence": {
                    "affiliation": {
                        "country": "United Kingdom",
                        "address-part": "2nd Floor, 90 High Holborn",
                        "postal-code": "WC1V 6LJ",
                        "@country": "gbr",
                        "city": "London",
                        "organization": [
                            {"$": "MRC Clinical Trials Unit at UCL"},
                            {"$": "Institute of Clinical Trials and Methodology"}
                        ],
                        "ce:source-text": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, 2nd Floor, 90 High Holborn, London WC1V 6LJ, United Kingdom"
                    },
                    "person": {
                        "ce:given-name": "Deborah",
                        "ce:initials": "D.",
                        "ce:degrees": "PhD",
                        "ce:surname": "Ford",
                        "ce:indexed-name": "Ford D."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Clinical trial design",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pediatric clinical trials",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pediatric HIV",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://journals.lww.com/jaids/pages/default.aspx",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Acquired Immune Deficiency Syndromes",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "78",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "S40",
                            "@last": "S48"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Acquired Immune Deficiency Syndromes",
                    "publicationdate": {
                        "month": "08",
                        "year": "2018",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 August 2018"
                        },
                        "day": "01"
                    },
                    "codencode": "JJASF",
                    "sourcetitle-abbrev": "J. Acquired Immune Defic. Syndr.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "10779450",
                            "@type": "electronic"
                        },
                        {
                            "$": "15254135",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2018"},
                    "publisher": {"publishername": "Lippincott Williams and Wilkins"},
                    "@srcid": "15300154823"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "17",
                                    "classification-description": "Public Health, Social Medicine and Epidemiology"
                                },
                                {
                                    "classification-code": "7",
                                    "classification-description": "Pediatrics and Pediatric Surgery"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2725"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "nlm",
                        "chemical": {"chemical-name": "Anti-Retroviral Agents"}
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "16",
                    "@timestamp": "BST 05:56:34",
                    "@year": "2023",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2016633691",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "624497184",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2022009816",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "938313580",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220108464",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "29994919",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20220316166",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20220422883",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20229001237126",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85055149780",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85055149780",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "624497184",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77780299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1097/QAI.0000000000001748"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "62",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236\u20131243.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "4744348948",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "364"},
                                "pagerange": {
                                    "@first": "1236",
                                    "@last": "1243"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Newell",
                                        "ce:indexed-name": "Newell ML"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Coovadia",
                                        "ce:indexed-name": "Coovadia H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Cortina-Borja",
                                        "ce:indexed-name": "Cortina-Borja M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236\u20131243."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Picat MQ, Lewis J, Musiime V, et al. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med. 2013;10:e1001542.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84886623702",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "e1001542"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MQ",
                                        "@_fa": "true",
                                        "ce:surname": "Picat",
                                        "ce:indexed-name": "Picat MQ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Lewis",
                                        "ce:indexed-name": "Lewis J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS Med"
                        },
                        "ce:source-text": "Picat MQ, Lewis J, Musiime V, et al. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med. 2013;10:e1001542."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Dunne J, Rodriguez WJ, Murphy MD, et al. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 2011; 128:e1242\u20131249.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Extrapolation of adult data and other data in pediatric drug-development programs"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80355131137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "e1242",
                                    "@last": "e1249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Dunne",
                                        "ce:indexed-name": "Dunne J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez",
                                        "ce:indexed-name": "Rodriguez WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MD",
                                        "@_fa": "true",
                                        "ce:surname": "Murphy",
                                        "ce:indexed-name": "Murphy MD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatrics"
                        },
                        "ce:source-text": "Dunne J, Rodriguez WJ, Murphy MD, et al. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 2011; 128:e1242\u20131249."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products: Guidance for Industry. 2014. Available at: https://www.fda.gov/downloads/drugs/guidances/ucm425885.pdf. Accessed November 13, 2017.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/downloads/drugs/guidances/ucm425885.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84939222131",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed November 13, 2017",
                            "ref-sourcetitle": "General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products: Guidance for Industry"
                        },
                        "ce:source-text": "General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products: Guidance for Industry. 2014. Available at: https://www.fda.gov/downloads/drugs/guidances/ucm425885.pdf. Accessed November 13, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2015. Available at: https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ guidances/ucm355128.pdf. Accessed June 13, 2018.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm355128.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018054863",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); Accessed June 13, 2018",
                            "ref-sourcetitle": "Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment Guidance for Industry"
                        },
                        "ce:source-text": "Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2015. Available at: https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ guidances/ucm355128.pdf. Accessed June 13, 2018."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u20131167.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0141857724",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "349"},
                                "pagerange": {
                                    "@first": "1157",
                                    "@last": "1167"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "GL",
                                        "@_fa": "true",
                                        "ce:surname": "Kearns",
                                        "ce:indexed-name": "Kearns GL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Abdel-Rahman",
                                        "ce:indexed-name": "Abdel-Rahman SM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SW",
                                        "@_fa": "true",
                                        "ce:surname": "Alander",
                                        "ce:indexed-name": "Alander SW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u20131167."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Penazzato M, Palladino C, Sugandhi N; Paediatric Antiretroviral Working Group. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up. Curr Opin HIV AIDS. 2017;12: 369\u2013376.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Paediatric Antiretroviral Working Group. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017580499",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "369",
                                    "@last": "376"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Penazzato",
                                    "ce:indexed-name": "Penazzato M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Palladino",
                                    "ce:indexed-name": "Palladino C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Sugandhi",
                                    "ce:indexed-name": "Sugandhi N"
                                }
                            ]},
                            "ref-sourcetitle": "Curr Opin HIV AIDS"
                        },
                        "ce:source-text": "Penazzato M, Palladino C, Sugandhi N; Paediatric Antiretroviral Working Group. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up. Curr Opin HIV AIDS. 2017;12: 369\u2013376."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Phelps BR, Rakhmanina N. Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges. Paediatric Drugs. 2011;13:175\u2013192.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79955122994",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "175",
                                    "@last": "192"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "BR",
                                    "@_fa": "true",
                                    "ce:surname": "Phelps",
                                    "ce:indexed-name": "Phelps BR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Rakhmanina",
                                    "ce:indexed-name": "Rakhmanina N."
                                }
                            ]},
                            "ref-sourcetitle": "Paediatric Drugs"
                        },
                        "ce:source-text": "Phelps BR, Rakhmanina N. Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges. Paediatric Drugs. 2011;13:175\u2013192."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Penazzato M, Gnanashanmugam D, Rojo P, et al. Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations. Clin Infect Dis. 2017;64:1597\u20131603.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85027359097",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1597",
                                    "@last": "1603"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Penazzato",
                                        "ce:indexed-name": "Penazzato M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Gnanashanmugam",
                                        "ce:indexed-name": "Gnanashanmugam D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rojo",
                                        "ce:indexed-name": "Rojo P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Penazzato M, Gnanashanmugam D, Rojo P, et al. Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations. Clin Infect Dis. 2017;64:1597\u20131603."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Rudan I, Gibson JL, Ameratunga S, et al. Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J. 2008;49:720\u2013733.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Setting priorities in global child health research investments: guidelines for implementation of CHNRI method"},
                            "refd-itemidlist": {"itemid": {
                                "$": "63249085127",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "720",
                                    "@last": "733"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Rudan",
                                        "ce:indexed-name": "Rudan I"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Gibson",
                                        "ce:indexed-name": "Gibson JL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ameratunga",
                                        "ce:indexed-name": "Ameratunga S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Croat Med J"
                        },
                        "ce:source-text": "Rudan I, Gibson JL, Ameratunga S, et al. Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J. 2008;49:720\u2013733."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Available at: https://www.iasociety.org/Web/WebContent/File/CHNRI_research_questions_ADO_and_PAEDS.pdf. Accessed November 30, 2017.",
                        "@id": "11",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.iasociety.org/Web/WebContent/File/CHNRI_research_questions_ADO_and_PAEDS.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123896700",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Available at: Accessed November 30, 2017"
                        },
                        "ce:source-text": "Available at: https://www.iasociety.org/Web/WebContent/File/CHNRI_research_questions_ADO_and_PAEDS.pdf. Accessed November 30, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865\u20131871.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "8844219810",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "364"},
                                "pagerange": {
                                    "@first": "1865",
                                    "@last": "1871"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Chintu",
                                        "ce:indexed-name": "Chintu C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GJ",
                                        "@_fa": "true",
                                        "ce:surname": "Bhat",
                                        "ce:indexed-name": "Bhat GJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AS",
                                        "@_fa": "true",
                                        "ce:surname": "Walker",
                                        "ce:indexed-name": "Walker AS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865\u20131871."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "World Health Organization. Guidelines on Co-trimoxazole Prophylaxis for HIV-related Infections Among Children, Adolescents and Adults. 2006. Available at: http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf?ua=1. Accessed December 12, 2017.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "34248178456",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed December 12, 2017",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Health Organization",
                                "ce:indexed-name": "World Health Organization"
                            }},
                            "ref-sourcetitle": "Guidelines on Co-trimoxazole Prophylaxis for HIV-related Infections Among Children, Adolescents and Adults"
                        },
                        "ce:source-text": "World Health Organization. Guidelines on Co-trimoxazole Prophylaxis for HIV-related Infections Among Children, Adolescents and Adults. 2006. Available at: http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf?ua=1. Accessed December 12, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Puthanakit T, Saphonn V, Ananworanich J, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12:933\u2013941.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84869865451",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "933",
                                    "@last": "941"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Puthanakit",
                                        "ce:indexed-name": "Puthanakit T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Saphonn",
                                        "ce:indexed-name": "Saphonn V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Ananworanich",
                                        "ce:indexed-name": "Ananworanich J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Puthanakit T, Saphonn V, Ananworanich J, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12:933\u2013941."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Parmar MK, Carpenter J, Sydes MR. More multiarm randomised trials of superiority are needed. Lancet. 2014;384:283\u2013284.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "More multiarm randomised trials of superiority are needed"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84904793436",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "384"},
                                "pagerange": {
                                    "@first": "283",
                                    "@last": "284"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MK",
                                    "@_fa": "true",
                                    "ce:surname": "Parmar",
                                    "ce:indexed-name": "Parmar MK"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Carpenter",
                                    "ce:indexed-name": "Carpenter J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MR.",
                                    "@_fa": "true",
                                    "ce:surname": "Sydes",
                                    "ce:indexed-name": "Sydes MR."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Parmar MK, Carpenter J, Sydes MR. More multiarm randomised trials of superiority are needed. Lancet. 2014;384:283\u2013284."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clinical trials. J R Stat Soc A. 1996;159:93\u2013110.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1996"},
                            "ref-title": {"ref-titletext": "Multiplicity considerations in the design and analysis of clinical trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0038975320",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "159"},
                                "pagerange": {
                                    "@first": "93",
                                    "@last": "110"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RJ",
                                    "@_fa": "true",
                                    "ce:surname": "Cook",
                                    "ce:indexed-name": "Cook RJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "VT.",
                                    "@_fa": "true",
                                    "ce:surname": "Farewell",
                                    "ce:indexed-name": "Farewell VT."
                                }
                            ]},
                            "ref-sourcetitle": "J R Stat Soc A"
                        },
                        "ce:source-text": "Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clinical trials. J R Stat Soc A. 1996;159:93\u2013110."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet. 2005;365:1591\u20131595.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Multiplicity in randomised trials I: endpoints and treatments"},
                            "refd-itemidlist": {"itemid": {
                                "$": "18144385438",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "365"},
                                "pagerange": {
                                    "@first": "1591",
                                    "@last": "1595"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "KF",
                                    "@_fa": "true",
                                    "ce:surname": "Schulz",
                                    "ce:indexed-name": "Schulz KF"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DA.",
                                    "@_fa": "true",
                                    "ce:surname": "Grimes",
                                    "ce:indexed-name": "Grimes DA."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet. 2005;365:1591\u20131595."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. New Engl J Med. 2008;359:2233\u20132244.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Early antiretroviral therapy and mortality among HIV-infected infants"},
                            "refd-itemidlist": {"itemid": {
                                "$": "56749097184",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "2233",
                                    "@last": "2244"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Violari",
                                        "ce:indexed-name": "Violari A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Cotton",
                                        "ce:indexed-name": "Cotton MF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DM",
                                        "@_fa": "true",
                                        "ce:surname": "Gibb",
                                        "ce:indexed-name": "Gibb DM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. New Engl J Med. 2008;359:2233\u20132244."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cotton MF, Violari A, Otwombe K, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555\u20131563.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84887243970",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "382"},
                                "pagerange": {
                                    "@first": "1555",
                                    "@last": "1563"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Cotton",
                                        "ce:indexed-name": "Cotton MF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Violari",
                                        "ce:indexed-name": "Violari A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Otwombe",
                                        "ce:indexed-name": "Otwombe K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Cotton MF, Violari A, Otwombe K, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555\u20131563."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "WHO Paediatric Guideline Group meeting. Paediatric HIV/antiretroviral Therapy and Care Guideline Review. Geneva, Switzerland. 2008. Available at: http://www.who.int/hiv/pub/meetingreports/Summary_report_closing.pdf?ua=1. http://www.who.int/hiv/pub/paediatric/art_meeting_april2008/en/. Accessed June 13, 2018.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/hiv/pub/meetingreports/Summary_report_closing.pdf?ua=1.http://www.who.int/hiv/pub/paediatric/art_meeting_april2008/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892370642",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Geneva, Switzerland. Accessed June 13, 2018",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "WHO Paediatric Guideline Group meeting",
                                "ce:indexed-name": "WHO Paediatric Guideline Group meeting"
                            }},
                            "ref-sourcetitle": "Paediatric HIV/antiretroviral Therapy and Care Guideline Review"
                        },
                        "ce:source-text": "WHO Paediatric Guideline Group meeting. Paediatric HIV/antiretroviral Therapy and Care Guideline Review. Geneva, Switzerland. 2008. Available at: http://www.who.int/hiv/pub/meetingreports/Summary_report_closing.pdf?ua=1. http://www.who.int/hiv/pub/paediatric/art_meeting_april2008/en/. Accessed June 13, 2018."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mulenga V, Musiime V, Kekitiinwa A, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016;16:169\u2013179.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84957707710",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "169",
                                    "@last": "179"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Mulenga",
                                        "ce:indexed-name": "Mulenga V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kekitiinwa",
                                        "ce:indexed-name": "Kekitiinwa A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Mulenga V, Musiime V, Kekitiinwa A, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016;16:169\u2013179."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "ARROW Trial Team, Kekitiinwa A, Cook A, Nathoo K, et al. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381:1391\u20131403.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876280807",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "381"},
                                "pagerange": {
                                    "@first": "1391",
                                    "@last": "1403"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kekitiinwa",
                                        "ce:indexed-name": "Kekitiinwa A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Cook",
                                        "ce:indexed-name": "Cook A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Nathoo",
                                        "ce:indexed-name": "Nathoo K"
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "4",
                                    "ce:text": "ARROW Trial Team",
                                    "ce:indexed-name": "ARROW Trial Team"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "ARROW Trial Team, Kekitiinwa A, Cook A, Nathoo K, et al. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381:1391\u20131403."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Montgomery AA, Peters TJ, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol. 2003;3:26.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Design, analysis and presentation of factorial randomised controlled trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3042728223",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {"@first": "26"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AA",
                                    "@_fa": "true",
                                    "ce:surname": "Montgomery",
                                    "ce:indexed-name": "Montgomery AA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TJ",
                                    "@_fa": "true",
                                    "ce:surname": "Peters",
                                    "ce:indexed-name": "Peters TJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Little",
                                    "ce:indexed-name": "Little P."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Med Res Methodol"
                        },
                        "ce:source-text": "Montgomery AA, Peters TJ, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol. 2003;3:26."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Penpact Study Team, Babiker A, Castro nee Green H, Compagnucci A, et al. First-line antiretroviral therapy with a protease inhibitor versus nonnucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis. 2011;11:273\u2013283.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "First-line antiretroviral therapy with a protease inhibitor versus nonnucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79953054005",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "273",
                                    "@last": "283"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Babiker",
                                        "ce:indexed-name": "Babiker A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Castro nee Green",
                                        "ce:indexed-name": "Castro nee Green H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Compagnucci",
                                        "ce:indexed-name": "Compagnucci A"
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "4",
                                    "ce:text": "Penpact Study Team",
                                    "ce:indexed-name": "Penpact Study Team"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Penpact Study Team, Babiker A, Castro nee Green H, Compagnucci A, et al. First-line antiretroviral therapy with a protease inhibitor versus nonnucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis. 2011;11:273\u2013283."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Walker AS, Prendergast AJ, Mugyenyi P, et al. Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis. 2012;55:1707\u20131718.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84870223640",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "55"},
                                "pagerange": {
                                    "@first": "1707",
                                    "@last": "1718"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AS",
                                        "@_fa": "true",
                                        "ce:surname": "Walker",
                                        "ce:indexed-name": "Walker AS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Prendergast",
                                        "ce:indexed-name": "Prendergast AJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Mugyenyi",
                                        "ce:indexed-name": "Mugyenyi P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Walker AS, Prendergast AJ, Mugyenyi P, et al. Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis. 2012;55:1707\u20131718."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Hakim J, Musiime V, Szubert AJ, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. New Engl J Med. 2017;377:233\u2013245.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85025650137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "233",
                                    "@last": "245"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Hakim",
                                        "ce:indexed-name": "Hakim J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Szubert",
                                        "ce:indexed-name": "Szubert AJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Hakim J, Musiime V, Szubert AJ, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. New Engl J Med. 2017;377:233\u2013245."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Musiime V, Kasirye P, Naidoo-James B, et al. Once vs twice-daily abacavir and lamivudine in African children. AIDS. 2016;30:1761\u20131770.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Once vs twice-daily abacavir and lamivudine in African children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84963700072",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "1761",
                                    "@last": "1770"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Kasirye",
                                        "ce:indexed-name": "Kasirye P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Naidoo-James",
                                        "ce:indexed-name": "Naidoo-James B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Musiime V, Kasirye P, Naidoo-James B, et al. Once vs twice-daily abacavir and lamivudine in African children. AIDS. 2016;30:1761\u20131770."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, et al. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. New Engl J Med. 2014;370:41\u201353.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892170982",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "370"},
                                "pagerange": {
                                    "@first": "41",
                                    "@last": "53"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bwakura-Dangarembizi",
                                        "ce:indexed-name": "Bwakura-Dangarembizi M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Kendall",
                                        "ce:indexed-name": "Kendall L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Bakeera-Kitaka",
                                        "ce:indexed-name": "Bakeera-Kitaka S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, et al. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. New Engl J Med. 2014;370:41\u201353."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Parmar MK, Sydes MR, Cafferty FH, et al. Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: multi-arm, multi-stage platform, umbrella and basket protocols. Clin Trials. 2017;14:451\u2013461.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: multi-arm, multi-stage platform, umbrella and basket protocols"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030685836",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "451",
                                    "@last": "461"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MK",
                                        "@_fa": "true",
                                        "ce:surname": "Parmar",
                                        "ce:indexed-name": "Parmar MK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Sydes",
                                        "ce:indexed-name": "Sydes MR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "FH",
                                        "@_fa": "true",
                                        "ce:surname": "Cafferty",
                                        "ce:indexed-name": "Cafferty FH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Trials"
                        },
                        "ce:source-text": "Parmar MK, Sydes MR, Cafferty FH, et al. Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: multi-arm, multi-stage platform, umbrella and basket protocols. Clin Trials. 2017;14:451\u2013461."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Palumbo P, Lindsey JC, Hughes MD, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. New Engl J Med. 2010; 363:1510\u20131520.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Antiretroviral treatment for children with peripartum nevirapine exposure"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77957951312",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "363"},
                                "pagerange": {
                                    "@first": "1510",
                                    "@last": "1520"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Palumbo",
                                        "ce:indexed-name": "Palumbo P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Lindsey",
                                        "ce:indexed-name": "Lindsey JC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MD",
                                        "@_fa": "true",
                                        "ce:surname": "Hughes",
                                        "ce:indexed-name": "Hughes MD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Palumbo P, Lindsey JC, Hughes MD, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. New Engl J Med. 2010; 363:1510\u20131520."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Violari A, Lindsey JC, Hughes MD, et al. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. New Engl J Med. 2012;366: 2380\u20132389.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862518618",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "366"},
                                "pagerange": {
                                    "@first": "2380",
                                    "@last": "2389"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Violari",
                                        "ce:indexed-name": "Violari A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Lindsey",
                                        "ce:indexed-name": "Lindsey JC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MD",
                                        "@_fa": "true",
                                        "ce:surname": "Hughes",
                                        "ce:indexed-name": "Hughes MD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Violari A, Lindsey JC, Hughes MD, et al. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. New Engl J Med. 2012;366: 2380\u20132389."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Barlow-Mosha L, Angelidou K, Lindsey J, et al. Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial. Clin Infect Dis. 2016;63:1113\u20131121.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84991000836",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "1113",
                                    "@last": "1121"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Barlow-Mosha",
                                        "ce:indexed-name": "Barlow-Mosha L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Angelidou",
                                        "ce:indexed-name": "Angelidou K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Lindsey",
                                        "ce:indexed-name": "Lindsey J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Barlow-Mosha L, Angelidou K, Lindsey J, et al. Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial. Clin Infect Dis. 2016;63:1113\u20131121."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Word Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2013. Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1 Accessed December 14, 2017.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882279538",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed December 14, 2017",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Word Health Organization",
                                "ce:indexed-name": "Word Health Organization"
                            }},
                            "ref-sourcetitle": "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection"
                        },
                        "ce:source-text": "Word Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2013. Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1 Accessed December 14, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "NIH ClinicalTrials.gov. A Randomised Trial of Dolutegravir (DTG)Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children with HIV Infection Starting First-line or Switching to Second-line ART. Available at: https://clinicaltrials.gov/ct2/show/NCT02259127?term=odyssey&cond=HIV%2FAIDS&rank=1 Accessed December 14, 2017.",
                        "@id": "34",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://clinicaltrials.gov/ct2/show/NCT02259127?term=odyssey&cond=HIV%2FAIDS&rank=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123894559",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "NIH ClinicalTrials.gov. Accessed December 14, 2017",
                            "ref-sourcetitle": "A Randomised Trial of Dolutegravir (DTG)Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children with HIV Infection Starting First-line or Switching to Second-line ART"
                        },
                        "ce:source-text": "NIH ClinicalTrials.gov. A Randomised Trial of Dolutegravir (DTG)Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children with HIV Infection Starting First-line or Switching to Second-line ART. Available at: https://clinicaltrials.gov/ct2/show/NCT02259127?term=odyssey&cond=HIV%2FAIDS&rank=1 Accessed December 14, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kairalla JA, Coffey CS, Thomann MA, et al. Adaptive trial designs: a review of barriers and opportunities. Trials. 2012;13:145.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Adaptive trial designs: a review of barriers and opportunities"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865271518",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "145"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JA",
                                        "@_fa": "true",
                                        "ce:surname": "Kairalla",
                                        "ce:indexed-name": "Kairalla JA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CS",
                                        "@_fa": "true",
                                        "ce:surname": "Coffey",
                                        "ce:indexed-name": "Coffey CS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Thomann",
                                        "ce:indexed-name": "Thomann MA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Trials"
                        },
                        "ce:source-text": "Kairalla JA, Coffey CS, Thomann MA, et al. Adaptive trial designs: a review of barriers and opportunities. Trials. 2012;13:145."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Curtin F, Heritier S. The role of adaptive trial designs in drug development. Expert Rev Clin Pharmacol. 2017;10:727\u2013736.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The role of adaptive trial designs in drug development"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85021098083",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "727",
                                    "@last": "736"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Curtin",
                                    "ce:indexed-name": "Curtin F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Heritier",
                                    "ce:indexed-name": "Heritier S."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Clin Pharmacol"
                        },
                        "ce:source-text": "Curtin F, Heritier S. The role of adaptive trial designs in drug development. Expert Rev Clin Pharmacol. 2017;10:727\u2013736."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Parmar MK, Barthel FM, Sydes M, et al. Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 2008;100:1204\u20131214.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Speeding up the evaluation of new agents in cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "51749123391",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "100"},
                                "pagerange": {
                                    "@first": "1204",
                                    "@last": "1214"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MK",
                                        "@_fa": "true",
                                        "ce:surname": "Parmar",
                                        "ce:indexed-name": "Parmar MK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FM",
                                        "@_fa": "true",
                                        "ce:surname": "Barthel",
                                        "ce:indexed-name": "Barthel FM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Sydes",
                                        "ce:indexed-name": "Sydes M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Parmar MK, Barthel FM, Sydes M, et al. Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 2008;100:1204\u20131214."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Musiime V, Fillekes Q, Kekitiinwa A, et al. The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in African HIV-infected children. J Acquir Immune Defic Syndr. 2014; 66:148\u2013154.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in African HIV-infected children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84901331937",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "148",
                                    "@last": "154"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q",
                                        "@_fa": "true",
                                        "ce:surname": "Fillekes",
                                        "ce:indexed-name": "Fillekes Q"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kekitiinwa",
                                        "ce:indexed-name": "Kekitiinwa A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Musiime V, Fillekes Q, Kekitiinwa A, et al. The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in African HIV-infected children. J Acquir Immune Defic Syndr. 2014; 66:148\u2013154."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kekitiinwa A, Musiime V, Thomason MJ, et al. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. Antivir Ther. 2016;21:579\u2013585.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85006094536",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "579",
                                    "@last": "585"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kekitiinwa",
                                        "ce:indexed-name": "Kekitiinwa A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Musiime",
                                        "ce:indexed-name": "Musiime V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Thomason",
                                        "ce:indexed-name": "Thomason MJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antivir Ther"
                        },
                        "ce:source-text": "Kekitiinwa A, Musiime V, Thomason MJ, et al. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. Antivir Ther. 2016;21:579\u2013585."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Torgerson DJ. Contamination in trials: is cluster randomisation the answer? Br Med J. 2001;2001:355\u2013357.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Contamination in trials: is cluster randomisation the answer?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035835406",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2001"},
                                "pagerange": {
                                    "@first": "355",
                                    "@last": "357"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "DJ.",
                                "@_fa": "true",
                                "ce:surname": "Torgerson",
                                "ce:indexed-name": "Torgerson DJ."
                            }]},
                            "ref-sourcetitle": "Br Med J"
                        },
                        "ce:source-text": "Torgerson DJ. Contamination in trials: is cluster randomisation the answer? Br Med J. 2001;2001:355\u2013357."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. Br Med J. 2003;327:785\u2013789.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0141639672",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "327"},
                                "pagerange": {
                                    "@first": "785",
                                    "@last": "789"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Puffer",
                                    "ce:indexed-name": "Puffer S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Torgerson",
                                    "ce:indexed-name": "Torgerson D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Watson",
                                    "ce:indexed-name": "Watson J."
                                }
                            ]},
                            "ref-sourcetitle": "Br Med J"
                        },
                        "ce:source-text": "Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. Br Med J. 2003;327:785\u2013789."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Foster G, Kangwende A, Magezi V, et al. Cluster randomized trial on the effect of mother support groups on retention-in-care and PMTCT outcomes in Zimbabwe: study design, challenges, and national relevance. J Acquir Immune Defic Syndr. 2014;67(suppl 2):S145\u2013S149.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Cluster randomized trial on the effect of mother support groups on retention-in-care and PMTCT outcomes in Zimbabwe: study design, challenges, and national relevance"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925547599",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "S145",
                                    "@last": "S149"
                                }
                            },
                            "ref-text": "(suppl 2)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Foster",
                                        "ce:indexed-name": "Foster G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kangwende",
                                        "ce:indexed-name": "Kangwende A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Magezi",
                                        "ce:indexed-name": "Magezi V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Foster G, Kangwende A, Magezi V, et al. Cluster randomized trial on the effect of mother support groups on retention-in-care and PMTCT outcomes in Zimbabwe: study design, challenges, and national relevance. J Acquir Immune Defic Syndr. 2014;67(suppl 2):S145\u2013S149."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Tomlinson M, Doherty T, Ijumba P, et al. Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health. 2014;19:256\u2013266.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893812269",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "256",
                                    "@last": "266"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Tomlinson",
                                        "ce:indexed-name": "Tomlinson M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Doherty",
                                        "ce:indexed-name": "Doherty T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Ijumba",
                                        "ce:indexed-name": "Ijumba P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Trop Med Int Health"
                        },
                        "ce:source-text": "Tomlinson M, Doherty T, Ijumba P, et al. Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health. 2014;19:256\u2013266."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mavhu W, Willis N, Mufuka J, et al. Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial. Trials. 2017;18:478.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85031670781",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "478"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Mavhu",
                                        "ce:indexed-name": "Mavhu W"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Willis",
                                        "ce:indexed-name": "Willis N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Mufuka",
                                        "ce:indexed-name": "Mufuka J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Trials"
                        },
                        "ce:source-text": "Mavhu W, Willis N, Mufuka J, et al. Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial. Trials. 2017;18:478."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "NIH ClinicalTrials.gov. Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents. Available at: https://clinicaltrials.gov/ct2/show/NCT01302847?term=children +dolutegravir&cond=Hiv&rank=1.",
                        "@id": "45",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://clinicaltrials.gov/ct2/show/NCT01302847?term=children+dolutegravir&cond=Hiv&rank=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123900592",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "NIH ClinicalTrials.gov",
                            "ref-sourcetitle": "Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents"
                        },
                        "ce:source-text": "NIH ClinicalTrials.gov. Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents. Available at: https://clinicaltrials.gov/ct2/show/NCT01302847?term=children +dolutegravir&cond=Hiv&rank=1."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Baiardi P, Giaquinto C, Girotto S, et al; Excellence TNo. Innovative study design for paediatric clinical trials. Eur J Clin Pharmacol. 2011;67 (suppl 1):109\u2013115.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Excellence TNo. Innovative study design for paediatric clinical trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79955616718",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "109",
                                    "@last": "115"
                                }
                            },
                            "ref-text": "(suppl 1)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Baiardi",
                                        "ce:indexed-name": "Baiardi P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Giaquinto",
                                        "ce:indexed-name": "Giaquinto C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Girotto",
                                        "ce:indexed-name": "Girotto S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "Baiardi P, Giaquinto C, Girotto S, et al; Excellence TNo. Innovative study design for paediatric clinical trials. Eur J Clin Pharmacol. 2011;67 (suppl 1):109\u2013115."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Gupta S, Faughnan ME, Tomlinson GA, et al. A framework for applying unfamiliar trial designs in studies of rare diseases. J Clin Epidemiol. 2011;64:1085\u20131094.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A framework for applying unfamiliar trial designs in studies of rare diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80052034189",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1085",
                                    "@last": "1094"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Gupta",
                                        "ce:indexed-name": "Gupta S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ME",
                                        "@_fa": "true",
                                        "ce:surname": "Faughnan",
                                        "ce:indexed-name": "Faughnan ME"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GA",
                                        "@_fa": "true",
                                        "ce:surname": "Tomlinson",
                                        "ce:indexed-name": "Tomlinson GA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Epidemiol"
                        },
                        "ce:source-text": "Gupta S, Faughnan ME, Tomlinson GA, et al. A framework for applying unfamiliar trial designs in studies of rare diseases. J Clin Epidemiol. 2011;64:1085\u20131094."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cornu C, Kassai B, Fisch R, et al. Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis. 2013;8:48.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Experimental designs for small randomised clinical trials: an algorithm for choice"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84875360328",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "48"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Cornu",
                                        "ce:indexed-name": "Cornu C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Kassai",
                                        "ce:indexed-name": "Kassai B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Fisch",
                                        "ce:indexed-name": "Fisch R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Orphanet J Rare Dis"
                        },
                        "ce:source-text": "Cornu C, Kassai B, Fisch R, et al. Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis. 2013;8:48."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lallemant M, Le Coeur S, Sirirungsi W, et al. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand. AIDS. 2015;29:2497\u20132507.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84947868974",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "2497",
                                    "@last": "2507"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lallemant",
                                        "ce:indexed-name": "Lallemant M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Le Coeur",
                                        "ce:indexed-name": "Le Coeur S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Sirirungsi",
                                        "ce:indexed-name": "Sirirungsi W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Lallemant M, Le Coeur S, Sirirungsi W, et al. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand. AIDS. 2015;29:2497\u20132507."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lallemant M, Amzal B, Urien S, et al. Antiretroviral intensification to prevent intrapartum HIV transmission in late comers. 2015. Oral presentation at: Eigth IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015); July 19\u201322, 2015; Vancouver, Canada. Abstract no. MOAC0204.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Antiretroviral intensification to prevent intrapartum HIV transmission in late comers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123899455",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Oral presentation at: Eigth IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015); July 19\u201322, 2015; Vancouver, Canada. Abstract no. MOAC0204",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lallemant",
                                        "ce:indexed-name": "Lallemant M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Amzal",
                                        "ce:indexed-name": "Amzal B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Urien",
                                        "ce:indexed-name": "Urien S"
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Lallemant M, Amzal B, Urien S, et al. Antiretroviral intensification to prevent intrapartum HIV transmission in late comers. 2015. Oral presentation at: Eigth IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015); July 19\u201322, 2015; Vancouver, Canada. Abstract no. MOAC0204."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sripan P, Le Coeur S, Ingsrisawang L, et al. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. Antivir Ther. 2016;21:435\u2013440.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84991493939",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "435",
                                    "@last": "440"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Sripan",
                                        "ce:indexed-name": "Sripan P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Le Coeur",
                                        "ce:indexed-name": "Le Coeur S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Ingsrisawang",
                                        "ce:indexed-name": "Ingsrisawang L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antivir Ther"
                        },
                        "ce:source-text": "Sripan P, Le Coeur S, Ingsrisawang L, et al. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. Antivir Ther. 2016;21:435\u2013440."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sripan P, Le Coeur S, Amzal B, et al. Modeling of in-utero and intrapartum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV. PLoS One. 2015;10:e0126647.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Modeling of in-utero and intrapartum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84930625488",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "e0126647"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Sripan",
                                        "ce:indexed-name": "Sripan P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Le Coeur",
                                        "ce:indexed-name": "Le Coeur S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Amzal",
                                        "ce:indexed-name": "Amzal B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Sripan P, Le Coeur S, Amzal B, et al. Modeling of in-utero and intrapartum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV. PLoS One. 2015;10:e0126647."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. New Engl J Med. 2000;343:982\u2013991.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0034610026",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "343"},
                                "pagerange": {
                                    "@first": "982",
                                    "@last": "991"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lallemant",
                                        "ce:indexed-name": "Lallemant M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Jourdain",
                                        "ce:indexed-name": "Jourdain G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Le Coeur",
                                        "ce:indexed-name": "Le Coeur S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. New Engl J Med. 2000;343:982\u2013991."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. New Engl J Med. 2004;351:217\u2013228.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3142656082",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "351"},
                                "pagerange": {
                                    "@first": "217",
                                    "@last": "228"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lallemant",
                                        "ce:indexed-name": "Lallemant M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Jourdain",
                                        "ce:indexed-name": "Jourdain G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Le Coeur",
                                        "ce:indexed-name": "Le Coeur S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "New Engl J Med"
                        },
                        "ce:source-text": "Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. New Engl J Med. 2004;351:217\u2013228."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Goodman SN, Sladky JTA Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre syndrome. Clin Trials. 2005;2:305\u2013310; discussion 364\u2013378.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre syndrome"},
                            "refd-itemidlist": {"itemid": {
                                "$": "24944463173",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "305",
                                    "@last": "310"
                                }
                            },
                            "ref-text": "discussion 364\u2013378",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SN",
                                    "@_fa": "true",
                                    "ce:surname": "Goodman",
                                    "ce:indexed-name": "Goodman SN"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JTA",
                                    "@_fa": "true",
                                    "ce:surname": "Sladky",
                                    "ce:indexed-name": "Sladky JTA"
                                }
                            ]},
                            "ref-sourcetitle": "Clin Trials"
                        },
                        "ce:source-text": "Goodman SN, Sladky JTA Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre syndrome. Clin Trials. 2005;2:305\u2013310; discussion 364\u2013378."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schoenfeld DA, Hui Z, Finkelstein DM. Bayesian design using adult data to augment pediatric trials. Clin Trials. 2009;6:297\u2013304.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Bayesian design using adult data to augment pediatric trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70449723061",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "297",
                                    "@last": "304"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DA",
                                    "@_fa": "true",
                                    "ce:surname": "Schoenfeld",
                                    "ce:indexed-name": "Schoenfeld DA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "Hui",
                                    "ce:indexed-name": "Hui Z"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DM.",
                                    "@_fa": "true",
                                    "ce:surname": "Finkelstein",
                                    "ce:indexed-name": "Finkelstein DM."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Trials"
                        },
                        "ce:source-text": "Schoenfeld DA, Hui Z, Finkelstein DM. Bayesian design using adult data to augment pediatric trials. Clin Trials. 2009;6:297\u2013304."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Huff RA, Maca JD, Puri M, et al. Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics. Pediatr Res. 2017;82: 814\u2013821.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85031746448",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "82"},
                                "pagerange": {
                                    "@first": "814",
                                    "@last": "821"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Huff",
                                        "ce:indexed-name": "Huff RA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JD",
                                        "@_fa": "true",
                                        "ce:surname": "Maca",
                                        "ce:indexed-name": "Maca JD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Puri",
                                        "ce:indexed-name": "Puri M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatr Res"
                        },
                        "ce:source-text": "Huff RA, Maca JD, Puri M, et al. Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics. Pediatr Res. 2017;82: 814\u2013821."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kaur A, Skoner D, Ibrahim J, et al. Effect of grass sublingual tablet immunotherapy is similar in children and adults: a Bayesian approach to design pediatric sublingual immunotherapy trials. J Allergy Clin Immunol. 2018;141:1744\u20131749.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Effect of grass sublingual tablet immunotherapy is similar in children and adults: a Bayesian approach to design pediatric sublingual immunotherapy trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044392615",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "141"},
                                "pagerange": {
                                    "@first": "1744",
                                    "@last": "1749"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kaur",
                                        "ce:indexed-name": "Kaur A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Skoner",
                                        "ce:indexed-name": "Skoner D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Ibrahim",
                                        "ce:indexed-name": "Ibrahim J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Kaur A, Skoner D, Ibrahim J, et al. Effect of grass sublingual tablet immunotherapy is similar in children and adults: a Bayesian approach to design pediatric sublingual immunotherapy trials. J Allergy Clin Immunol. 2018;141:1744\u20131749."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "BMC ISRCTN registry. SHINE study: Shorter treatment for minimal TB in children. Available at: http://www.isrctn.com/ISRCTN63579542. Accessed December 14, 2017.",
                        "@id": "59",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.isrctn.com/ISRCTN63579542",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123897484",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "BMC ISRCTN registry. Accessed December 14, 2017",
                            "ref-sourcetitle": "SHINE study: Shorter treatment for minimal TB in children"
                        },
                        "ce:source-text": "BMC ISRCTN registry. SHINE study: Shorter treatment for minimal TB in children. Available at: http://www.isrctn.com/ISRCTN63579542. Accessed December 14, 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC). Sovaldi 400 mg film coated tablets. Available at: https://www.medicines.org.uk/emc/medicine/28539. Accessed June 13, 2018.",
                        "@id": "60",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.medicines.org.uk/emc/medicine/28539",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123898935",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed June 13, 2018",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Datapharm Communications Ltd",
                                "ce:indexed-name": "Datapharm Communications Ltd"
                            }},
                            "ref-sourcetitle": "Electronic Medicines Compendium (eMC). Sovaldi 400 mg film coated tablets"
                        },
                        "ce:source-text": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC). Sovaldi 400 mg film coated tablets. Available at: https://www.medicines.org.uk/emc/medicine/28539. Accessed June 13, 2018."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC). Harvoni 90 mg/400 mg film-coated tablets. Available at: https://www.medicines.org.uk/emc/medicine/29471. Accessed June 13, 2018.",
                        "@id": "61",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.medicines.org.uk/emc/medicine/29471",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85123896817",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Harvoni 90 mg/400 mg film-coated tablets. Accessed June 13, 2018",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC)",
                                "ce:indexed-name": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC)"
                            }}
                        },
                        "ce:source-text": "Datapharm Communications Ltd. Electronic Medicines Compendium (eMC). Harvoni 90 mg/400 mg film-coated tablets. Available at: https://www.medicines.org.uk/emc/medicine/29471. Accessed June 13, 2018."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2:900\u2013909.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85033464902",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "900",
                                    "@last": "909"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CW",
                                        "@_fa": "true",
                                        "ce:surname": "Spearman",
                                        "ce:indexed-name": "Spearman CW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Afihene",
                                        "ce:indexed-name": "Afihene M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Ally",
                                        "ce:indexed-name": "Ally R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2:900\u2013909."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lusaka",
            "@id": "60072805",
            "affilname": "University Teaching Hospital Lusaka",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072805",
            "affiliation-country": "Zambia"
        },
        {
            "affiliation-city": "Lusaka",
            "@id": "60072796",
            "affilname": "University of Zambia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072796",
            "affiliation-country": "Zambia"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071691",
            "affilname": "Joint Clinical Research Center Uganda",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071691",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071676",
            "affilname": "Makerere University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071676",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Harare",
            "@id": "60033774",
            "affilname": "University of Zimbabwe",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033774",
            "affiliation-country": "Zimbabwe"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60032499",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "60027142",
            "affilname": "Organisation Mondiale de la Santé",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027142",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "London",
            "@id": "60022148",
            "affilname": "University College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Johannesburg",
            "@id": "60016218",
            "affilname": "University of the Witwatersrand, Johannesburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016218",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85055149780",
        "dc:description": "For HIV-infected children, formulation development, pharmacokinetic (PK) data, and evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence of efficacy in children may not be needed if acceptable safety and PK parameters are demonstrated in children. However, it is important to address questions where adult trial data cannot be extrapolated to children. In this fast-moving area, interventions need to be tailored to resource-limited settings where most HIV-infected children live and take account of decreasing numbers of younger HIV-infected children after successful prevention of mother-to-child HIV transmission. Innovative randomized controlled trial (RCT) designs enable several questions relevant to children\u2019s treatment and care to be answered within the same study. We reflect on key considerations, and, with examples, discuss the relative merits of different RCT designs for addressing multiple scientific questions including parallel multi-arm RCTs, factorial RCTs, and crossover RCTs. We discuss inclusion of several populations (eg, untreated and pretreated children; children and adults) in \u201cbasket\u201d trials; incorporation of secondary randomizations after enrollment and use of nested substudies (particularly PK and formulation acceptability) within large RCTs. We review the literature on trial designs across other disease areas in pediatrics and rare diseases and discuss their relevance for addressing questions relevant to HIV-infected children; we provide an example of a Bayesian trial design in prevention of mother-to-child HIV transmission and consider this approach for future pediatric trials. Finally, we discuss the relevance of these approaches to other areas, in particular, childhood tuberculosis and hepatitis.",
        "pubmed-id": "29994919",
        "prism:coverDate": "2018-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85055149780",
        "dc:creator": {"author": [{
            "ce:given-name": "Deborah",
            "preferred-name": {
                "ce:given-name": "Deborah",
                "ce:initials": "D.",
                "ce:surname": "Ford",
                "ce:indexed-name": "Ford D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022148",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Ford",
            "@auid": "7401568316",
            "author-url": "https://api.elsevier.com/content/author/author_id/7401568316",
            "ce:indexed-name": "Ford D."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85055149780"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055149780&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85055149780&origin=inward"
            }
        ],
        "source-id": "15300154823",
        "citedby-count": "7",
        "prism:volume": "78",
        "subtype": "ar",
        "dc:title": "Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV",
        "openaccess": "1",
        "prism:issn": "10779450 15254135",
        "publishercopyright": "Copyright © 2018 The Author(s).",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Acquired Immune Deficiency Syndromes",
        "prism:pageRange": "S40-S48",
        "prism:endingPage": "S48",
        "openaccessFlag": "true",
        "prism:doi": "10.1097/QAI.0000000000001748",
        "prism:startingPage": "S40",
        "dc:identifier": "SCOPUS_ID:85055149780",
        "dc:publisher": "Lippincott Williams and Wilkins"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anti-Retroviral Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Bayes Theorem",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Clinical Trials as Topic",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Drug Compounding",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infectious Disease Transmission, Vertical",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pediatrics",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Clinical trial design"
        },
        {
            "@_fa": "true",
            "$": "Pediatric clinical trials"
        },
        {
            "@_fa": "true",
            "$": "Pediatric HIV"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Deborah",
            "preferred-name": {
                "ce:given-name": "Deborah",
                "ce:initials": "D.",
                "ce:surname": "Ford",
                "ce:indexed-name": "Ford D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022148",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Ford",
            "@auid": "7401568316",
            "author-url": "https://api.elsevier.com/content/author/author_id/7401568316",
            "ce:indexed-name": "Ford D."
        },
        {
            "ce:given-name": "Rebecca",
            "preferred-name": {
                "ce:given-name": "Rebecca",
                "ce:initials": "R.",
                "ce:surname": "Turner",
                "ce:indexed-name": "Turner R."
            },
            "@seq": "2",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022148",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Turner",
            "@auid": "7404556631",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404556631",
            "ce:indexed-name": "Turner R."
        },
        {
            "ce:given-name": "Anna",
            "preferred-name": {
                "ce:given-name": "Anna",
                "ce:initials": "A.",
                "ce:surname": "Turkova",
                "ce:indexed-name": "Turkova A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022148",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148"
            },
            "ce:degrees": "MRCPCH",
            "ce:surname": "Turkova",
            "@auid": "26031175500",
            "author-url": "https://api.elsevier.com/content/author/author_id/26031175500",
            "ce:indexed-name": "Turkova A."
        },
        {
            "ce:given-name": "Martina",
            "preferred-name": {
                "ce:given-name": "Martina",
                "ce:initials": "M.",
                "ce:surname": "Penazzato",
                "ce:indexed-name": "Penazzato M."
            },
            "@seq": "4",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027142",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027142"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Penazzato",
            "@auid": "57192121240",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192121240",
            "ce:indexed-name": "Penazzato M."
        },
        {
            "ce:given-name": "Victor",
            "preferred-name": {
                "ce:given-name": "Victor",
                "ce:initials": "V.",
                "ce:surname": "Musiime",
                "ce:indexed-name": "Musiime V."
            },
            "@seq": "5",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60071676",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071676"
                },
                {
                    "@id": "60071691",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071691"
                }
            ],
            "ce:degrees": "PhD",
            "ce:surname": "Musiime",
            "@auid": "17135681200",
            "author-url": "https://api.elsevier.com/content/author/author_id/17135681200",
            "ce:indexed-name": "Musiime V."
        },
        {
            "ce:given-name": "Mutsa",
            "preferred-name": {
                "ce:given-name": "Mutsa",
                "ce:initials": "M.",
                "ce:surname": "Bwakura-Dangarembizi",
                "ce:indexed-name": "Bwakura-Dangarembizi M."
            },
            "@seq": "6",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60033774",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033774"
            },
            "ce:degrees": "MMed",
            "ce:surname": "Bwakura-Dangarembizi",
            "@auid": "36670936700",
            "author-url": "https://api.elsevier.com/content/author/author_id/36670936700",
            "ce:indexed-name": "Bwakura-Dangarembizi M."
        },
        {
            "ce:given-name": "Avy",
            "preferred-name": {
                "ce:given-name": "Avy",
                "ce:initials": "A.",
                "ce:surname": "Violari",
                "ce:indexed-name": "Violari A."
            },
            "@seq": "7",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016218",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016218"
            },
            "ce:degrees": "FCPaed",
            "ce:surname": "Violari",
            "@auid": "8674786700",
            "author-url": "https://api.elsevier.com/content/author/author_id/8674786700",
            "ce:indexed-name": "Violari A."
        },
        {
            "ce:given-name": "Chishala",
            "preferred-name": {
                "ce:given-name": "Chishala",
                "ce:initials": "C.",
                "ce:surname": "Chabala",
                "ce:indexed-name": "Chabala C."
            },
            "@seq": "8",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60072805",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072805"
                },
                {
                    "@id": "60072796",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072796"
                }
            ],
            "ce:degrees": "MMed",
            "ce:surname": "Chabala",
            "@auid": "55444254300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55444254300",
            "ce:indexed-name": "Chabala C."
        },
        {
            "ce:given-name": "Thanyawee",
            "preferred-name": {
                "ce:given-name": "Thanyawee",
                "ce:initials": "T.",
                "ce:surname": "Puthanakit",
                "ce:indexed-name": "Puthanakit T."
            },
            "@seq": "9",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:degrees": "MD",
            "ce:surname": "Puthanakit",
            "@auid": "8071686900",
            "author-url": "https://api.elsevier.com/content/author/author_id/8071686900",
            "ce:indexed-name": "Puthanakit T."
        },
        {
            "ce:given-name": "Tavitiya",
            "preferred-name": {
                "ce:given-name": "Tavitiya",
                "ce:initials": "T.",
                "ce:surname": "Sudjaritruk",
                "ce:indexed-name": "Sudjaritruk T."
            },
            "@seq": "10",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60032250",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250"
                },
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Sudjaritruk",
            "@auid": "36538198800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36538198800",
            "ce:indexed-name": "Sudjaritruk T."
        },
        {
            "ce:given-name": "Tim R.",
            "preferred-name": {
                "ce:given-name": "Tim R.",
                "ce:initials": "T.R.",
                "ce:surname": "Cressey",
                "ce:indexed-name": "Cressey T.R."
            },
            "@seq": "11",
            "ce:initials": "T.R.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60032499",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499"
                },
                {
                    "@id": "60020661",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661"
                }
            ],
            "ce:degrees": "PhD",
            "ce:surname": "Cressey",
            "@auid": "55966228800",
            "author-url": "https://api.elsevier.com/content/author/author_id/55966228800",
            "ce:indexed-name": "Cressey T.R."
        },
        {
            "ce:given-name": "Marc",
            "preferred-name": {
                "ce:given-name": "Marc",
                "ce:initials": "M.",
                "ce:surname": "Lallemant",
                "ce:indexed-name": "Lallemant M."
            },
            "@seq": "12",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60032499",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Lallemant",
            "@auid": "24387959100",
            "author-url": "https://api.elsevier.com/content/author/author_id/24387959100",
            "ce:indexed-name": "Lallemant M."
        },
        {
            "ce:given-name": "Diana M.",
            "preferred-name": {
                "ce:given-name": "Diana M.",
                "ce:initials": "D.M.",
                "ce:surname": "Gibb",
                "ce:indexed-name": "Gibb D.M."
            },
            "@seq": "13",
            "ce:initials": "D.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022148",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148"
            },
            "ce:degrees": "MD",
            "ce:surname": "Gibb",
            "@auid": "57220477488",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220477488",
            "ce:indexed-name": "Gibb D.M."
        }
    ]}
}}